In 2006, Novartis dedicated US$755 million in company citizenship initiatives all over the world, especially concentrating on improving upon access to medicines while in the producing earth by means of its Access to Medicine tasks, such as donations of medicines to patients affected by leprosy, tuberculosis, and malaria; Glivec affected https://www.social-bookmarking.org/en/harnessing-cutting-edge-techniques-for-advanced-pharmaceutical-outcomes